Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

Cost of Revenue

$11.12B

TTM · Period ending: Jun 30, 2026 · USD

AZN Cost of Revenue

Latest reported$11.12Bperiod endingJun 30, 2026

Latest reported$11.12Bperiod endingJun 30, 2026

AZN TTM Cost of Revenue ($0.00 → $11.12B)

TTM cost of revenue

High-resolution chart · PNG

AZN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	3,137,682,543
Mar 31, 2001	3,039,333,824
Dec 31, 2000	3,039,432,968
Sep 30, 2000	3,039,432,968
Jun 30, 2000	3,337,270,129
Mar 31, 2000	3,531,118,848
Dec 31, 1999	2,460,500,000
Sep 30, 1999	2,460,500,000
Jun 30, 1999	1,207,500,000
Mar 31, 1999	825,500,000
Dec 31, 1998	825,500,000
Sep 30, 1998	825,500,000
Jun 30, 1998	825,500,000
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	947,900,000
Dec 31, 1995	947,900,000
Sep 30, 1995	947,900,000
Jun 30, 1995	947,900,000
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.